Inadequate treatment with HMG-CoA reductase inhibitors by health care providers

Castelli, 1986, Incidence of coronary heart disease and lipoprotein cholesterol levels.The Framingham study, JAMA, 256, 2835, 10.1001/jama.1986.03380200073024 Neaton, 1992, Serum Cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial, Arch Intern Med, 152, 1490, 10.1001/archinte.1992.00400190110021 Levine, 1995, Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms, NEJM, 332, 512, 10.1056/NEJM199502233320807 Superko, 1994, Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management, Circulation, 90, 1056, 10.1161/01.CIR.90.2.1056 1994, Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S), Lancet, 344, 1383 1993, JAMA, 269, 3015, 10.1001/jama.1993.03500230097036 Grundy, 1988, HMG-CoA reductase inhibitors for treatment of hypercholesteremia, NEJM, 319, 24, 10.1056/NEJM198807073190105 Blum, 1994, Comparison of properties of four inhibitors of 3-Hydroxy-3-Methyglutaryl-Coenzyme A reductase, Am J Cardiol, 73, 3D, 10.1016/0002-9149(94)90626-2 1995, 732 1995, 1584 1995, 1655 1995, 2165 Giles, 1993, Recent trends in the identification and treatment of high blood cholesterol by physicians: progress and missed opportunities, JAMA, 269, 1133, 10.1001/jama.1993.03500090069035 Cohen, 1991, Low rate of treatment of hypercholesteremia by cardiologists in patients with suspected and proven coronary artery disease, Circulation, 83, 1294, 10.1161/01.CIR.83.4.1294 Blankenhorn, 1987, Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts, JAMA, 257, 3233, 10.1001/jama.1987.03390230069027 Brown, 1990, Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B, NEJM, 323, 1289, 10.1056/NEJM199011083231901 Buchwald, 1990, Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesteremia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH), NEJM, 323, 946, 10.1056/NEJM199010043231404 Kane, 1990, Regression of coronary atherosclerosis during treatment of familial hypercholesteremia with combined drug regimens, JAMA, 264, 3007, 10.1001/jama.1990.03450230043027 Sclar, 1991, Improving medication compliance: a review of selected issues, Clin Ther, 13, 436 Cramer, 1989, How often is medication taken as prescribed? A novel assessment technique, JAMA, 261, 3273, 10.1001/jama.1989.03420220087032